Home › NDC Lookup › RxCUI directory › RxCUI 207436

Rifampin 600 MG Injection [Rifadin] — RxCUI 207436

RxNorm drug concept · Semantic branded drug
RxCUI 207436 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI207436
Official nameRifampin 600 MG Injection [Rifadin]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asRifadin 600 MG Injection
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Rifampin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • That's completely expected with rifampin and nothing to worry about medically. The drug naturally gives a reddish-orange color to urine, sweat, saliva, tears, and even stool. It's...
  • Why is my urine and sweat turning orange? Is that dangerous?
  • Yes, this is a real and important concern. Rifampin significantly reduces the effectiveness of hormonal birth control — including the pill, patch, ring, and hormonal IUD. You shoul...
  • I've heard rifampin can affect my birth control. What should I do?
📖 Read our full Rifampin guide →

🕸️ Concept Web — How Rifampin 600 MG Injection [Rifadin] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Rifampin 600 MG Injection [Rifadin] RxCUI 207436

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Rifampin 9384
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Rifadin 202953
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Rifampin Injection 1863365
    • Rifampin Injectable Product 1165463
    • Rifampin Injection [Rifadin] 1863368
    • Rifadin Injectable Product 1184712
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Rifampin 600 MG Injection SCD · 312821
  • Rifampin 600 MG SCDC · 323964
  • Rifampin Injection SCDF · 1863365
  • Rifampin Injectable Product SCDG · 1165463

Brand-Name Concepts

  • Rifampin 600 MG [Rifadin] SBDC · 1863367
  • Rifampin Injection [Rifadin] SBDF · 1863368
  • Rifadin Injectable Product SBDG · 1184712
  • Rifadin BN · 202953

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 207436 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00068-0597-01 1 VIAL, GLASS in 1 CARTON (0068-0597-01) / 10 mL in 1 VIAL,... Rifadin IV Sanofi-Aventis U.S. LLC 1989-05-25
Observed labelers: Sanofi-Aventis U.S. LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J2804 Inj, rifampin, 1 mg 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.